The objective of this study was to analyze acute care utilization of sickle cell disease (SCD) and sickle cell trait (SCT) in children and identify trends in emergency department (ED) visits and inpatient admissions over a 10-year period. This is a retrospective population-based study of SCD- and SCT-related ED visits and admissions from 2006 to 2015. Data were acquired from the Healthcare Cost and Utilization Project (HCUP), National Inpatient Sample (NIS), and National Emergency Department Sample (NEDS) database. Cost-to-charge and estimated professional fee ratios were applied to approximate costs. Over 80% of medical expenditure on HbSS is through ED-based admissions. There is a statistically significant increase from 2006 to 2015 in the direct hospital admissions associated with patients less than 18 years of age who have been diagnosed with SCT.
Conclusion: Among patients less than 18 years of age with HbSS, inpatient admissions through the emergency department accounted for the largest medical expenditure of the SCD subtypes.
What is Known:|
• There are currently no multi-year, nationwide analyses of acute care utilization in sickle cell disease and sickle cell trait (SCT) in the pediatric population.
• SCT is more common than SCD, affecting 1.5% of all infants born in the USA.
What is New:
• Comprehensive annual costs of acute care utilization of patients less than 18 years of age with SCD and SCT in the USA which includes aggregated demographical patient care data and to illustrate temporal trends of acute care utilization in children less than 18 years of age with SCD and SCT
• Among patients less than 18 years of age with HbSS, inpatient admissions through the emergency department accounted for the largest medical expenditure of the sickle cell disease subtypes.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Annual percent change
Homozygous sickle cell disease
Healthcare Cost and Utilization Project
International Classification of Diseases, Ninth Edition, Clinical Modification
Kids’ Inpatient Database
National Emergency Department Sample
National Inpatient Sample
Professional fee ratio
Sickle cell disease
Sickle cell trait
Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM (2017) The accuracy of hospital ICD-9-CM codes for determining sickle cell disease genotype. J Rare Dis Res Treat 2(4):39–45
Kohne E (2011) Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int 108:532–540
Steiner CA, Miller JL. Sickle cell disease patients in U.S. hospitals, 2004: Statistical Brief #21. December 2006. Agency for Healthcare Research and Quality (US); 2006 Feb.
Habara A, Steinberg MH (2016) Minireview: genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood) 241(7):689–696
Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal. 9:46–67
Steinberg MH (2005) Predicting clinical severity in sickle cell anaemia. Br J Haematol 129(4):465–481
Figueiredo MS (2015) The compound state: Hb S/beta-thalassemia. Rev Bras Hematol Hemoter 37(3):150–152
Bachir D, Galacteros F (2004) Hemoglobin C disease. Orphanet Encylopedia
Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y (2009) Complications associated with sickle Cell trait: a brief narrative review. Am J Med 122(6):501–512
Tarini BA, Brooks MA, Bundy DG (2012) A policy impact analysis of the mandatory NCAA sickle cell trait screening program. Health Serv Res 47(1 Pt 2):446–461
Tantawy A (2014) The scope of clinical morbidity of sickle cell trait. Egyptian Journal of Medical Human Genetics 15:319–326
Naik RP, Haywood CJ (2015) Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program 1:160–167
Centers for Disease Control and Prevention (CDC) (2014) Incidence of sickle cell trait – United States, 2010. MMWR Morb Mortal Wkly Rep 63(49):1155–1158
Center for Disease Control and Prevention Data and Statistics on Sickle Cell Disease in the United States. Sickle cell Disease https://www.cdc.gov/ncbddd/sicklecell/data.html Accessed on April 11, 2020
Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA (2010) Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 202(13):1288–1294
Bou-Maroun LM, Meta F, Hanba CJ, Campbell AD, Yanik GA (2018) An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes. Pediatr Blood Cancer 65e26758
Shankar SM, Arbogast PG, Mitchel E, Cooper WO, Wang WC, Griffin MR (2005) Medical care utilization and mortality in sickle cell disease: a population based study. Am J Hematol 80(4):262–270
Davis H, Moore RM Jr, Gergen PJ (1997) Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 112:40–43
Overview of the Nationwide Emergency Department Databases. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/nedsoverview.jsp Accessed on April 11, 2020
Overview of the Nationwide Inpatient Databases. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. https://www.hcup-us.ahrq.gov/nisoverview.jsp Accessed on April 11, 2020
HCUP NIS Description of Data Elements. Healthcare Cost and Utilization Project (HCUP). September 2008. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/db/vars/totchg/nisnote.jsp. Accessed on April 11, 2020
Arth AC, Tinker SC, Simeone RM, Ailes EC, Cragan JD, Grosse SD (2017) Inpatient hospitalization costs associated with birth defects among persons of all ages - United States, 2013. MMWR Morb Mortal Wkly Rep 66(2):41–46
Salemi JL, Comins MM, Chandler K, Mogos MF, Salihu HM (2013a) A practical approach for calculating reliable cost estimates from observational data: application to cost analyses in maternal and child health. Appl Health Econ Health Policy 11(4):343–357
Cost-to-Charge Ratio Files. Healthcare Cost and Utilization Project (HCUP) (2018) Agency for healthcare research and quality, Rockville, MD. www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. Accessed on April 11, 2020
Peterson C, Xu L, Florence C, Grosse SD, Annest JL (2015) Professional fee ratios for US hospital discharge data [published correction appears in med care. 2016 Feb;54(2):218]. Med Care 53(10):840–849
Measuring Price Change in the Consumer Price Index: Medical care. https://www.bls.gov/cpi/factsheets/medical-care.htm. Accessed on April 11, 2020
Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, Haywood C Jr, Jenkins J, Lloyd-Puryear MA, Joiner CH, Bonham VL, Kato GJ (2018) Clinical outcomes associated with sickle cell trait: a systematic review. Ann Intern Med 169(9):619–627
Peterson C, Likang X, Florence C, Parks SE (2015) Annual cost of U.S. hospital visits for pediatric abusive head trauma. Child Maltreat 20(3):162–169
The United Nations Convention on the Rights of the Child https://www.unicef.org/child-rights-convention Accessed on April 11, 2020
This study was supported by the Health Resources and Services Administration (HRSA) (Grant No. 1 D3HP31024-01-00) for the project titled Baylor College of Medicine (BCM) Center of Excellence in Health Equity, Training & Research.
Conflict of interest
The authors declare that they have no conflict of interest.
This study was deemed exempt by the IRB of Baylor College of Medicine as the study was performed on secondary de-identified data.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Communicated by Peter de Winter
Electronic supplementary material
About this article
Cite this article
Peterson, E.E., Salemi, J.L., Dongarwar, D. et al. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost. Eur J Pediatr 179, 1701–1710 (2020). https://doi.org/10.1007/s00431-020-03656-x
- Sickle cell disease
- Sickle cell trait
- Emergency department